Rare diseases
Investigational molecules
Locations
Ul. Wejherowska 16, 60-446 Poznan, Poland
Reumedika s.c. in Poznan, Poland specialises in clinical trials of conditions such as Psoriatic arthropathy, Osteoarthritis, Rheumatoid arthritis, Psoriasis, and other specialisations. This site conducts important research.
The medical center is at the forefront of osteoarthritis research, focusing on innovative treatments and interventions to improve patient outcomes. The center's work is pivotal in understanding the structural changes in the knee, particularly in the central medial tibiofemoral compartment, which is crucial for developing effective therapies.
Through its research, the center contributes significantly to the advancement of therapeutic strategies, aiming to enhance the quality of life for individuals suffering from symptomatic knee osteoarthritis. The ongoing studies are designed to assess the efficacy, safety, and tolerability of new treatments, providing valuable insights into long-term patient care.
Clinical trials currently enrolling participants at this site.
Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
PolandEfficacy of intra‑articular allogeneic peripheral blood mononuclear cells induced to an early apoptotic state versus placebo in adults with primary knee osteoarthritis
PolandA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
PolandStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
PolandStudy on the Effects of LNA043 for Patients with Knee Osteoarthritis
PolandStudy of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment
PolandStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
PolandStudy on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation
PolandStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
PolandStudy on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
PolandStudy on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
